Grantham, Mayo, Van Otterloo & Co (GMO)’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-14,350
Closed -$1.01M 530
2018
Q2
$1.01M Sell
14,350
-250
-2% -$18K 0.01% 366
2018
Q1
$1.02M Sell
14,600
-1,900
-12% -$132K 0.01% 374
2017
Q4
$1.15M Buy
16,500
+7,100
+76% +$479K 0.01% 355
2017
Q3
$637K Buy
+9,400
New +$594K ﹤0.01% 404
2017
Q1
Sell
-120,316
Closed -$6.57M 584
2016
Q4
$6.57M Sell
120,316
-177,084
-60% -$10.1M 0.04% 224
2016
Q3
$19.5M Buy
297,400
+3,800
+1% +$248K 0.09% 161
2016
Q2
$17.7M Buy
293,600
+89,450
+44% +$5.2M 0.07% 178
2016
Q1
$11.5M Buy
+204,150
New +$12.3M 0.04% 227
2014
Q3
Sell
-28,000
Closed -$2.08M 435
2014
Q2
$2.08M Buy
+28,000
New +$2.02M 0.01% 362

Other funds holding AZN